Senior insider sale
Chief Commercial Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$9.69M
134.38K shares
What this filing means
MOTTIWALA AZIZ plans to sell 134.38K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $9.69M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/25/2026ACC: 0001959173-26-006443
Officer· Chief Commercial Officer
Since Oct 2020
134.38K
Shares to sell
$9.69M
Approx. market value
81.33K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/25/2026
81.33KTotal acquired81.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/25/2026 | Stock Option Exercise Cash | 81.33K | — |
| Total | 81.33K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
53.04K
Market value
$3.84M
8/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
81.33K
Market value
$5.84M
8/25/2026
Total
Units
134.38K
Value
$9.69M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/19/2026 | 53.04K | $3.84M | — | Completed |
| Planned — Approximate Date | ||||
8/25/2026 | 81.33K | $5.84M | NASDAQ | Planned |
| Total | 134.38K | $9.69M | ||